BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 12045167)

  • 1. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
    Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol improves endothelial dysfunction in chronic heart failure.
    Farquharson CA; Butler R; Hill A; Belch JJ; Struthers AD
    Circulation; 2002 Jul; 106(2):221-6. PubMed ID: 12105162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris.
    Rajendra NS; Ireland S; George J; Belch JJ; Lang CC; Struthers AD
    J Am Coll Cardiol; 2011 Aug; 58(8):820-8. PubMed ID: 21835317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure.
    Schwarz M; Katz SD; Demopoulos L; Hirsch H; Yuen JL; Jondeau G; LeJemtel TH
    Circulation; 1994 Apr; 89(4):1609-14. PubMed ID: 8149528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension.
    Butler R; Morris AD; Belch JJ; Hill A; Struthers AD
    Hypertension; 2000 Mar; 35(3):746-51. PubMed ID: 10720589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
    George J; Carr E; Davies J; Belch JJ; Struthers A
    Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients.
    Dogan A; Yarlioglues M; Kaya MG; Karadag Z; Dogan S; Ardic I; Dogdu O; Kilinc Y; Zencir C; Akpek M; Ozdogru I; Oguzhan A; Kalay N
    Blood Press; 2011 Jun; 20(3):182-7. PubMed ID: 21133824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.
    Katz SD; Schwarz M; Yuen J; LeJemtel TH
    Circulation; 1993 Jul; 88(1):55-61. PubMed ID: 8391403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters.
    Greig D; Alcaino H; Castro PF; Garcia L; Verdejo HE; Navarro M; López R; Mellado R; Tapia F; Gabrielli LA; Nogerol C; Chiong M; Godoy I; Lavandero S
    J Heart Lung Transplant; 2011 Apr; 30(4):408-13. PubMed ID: 21145258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers.
    Guthikonda S; Sinkey C; Barenz T; Haynes WG
    Circulation; 2003 Jan; 107(3):416-21. PubMed ID: 12551865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the most appropriate methodology for detection of conduit artery endothelial dysfunction?
    Guthikonda S; Sinkey CA; Haynes WG
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1172-6. PubMed ID: 17303783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol.
    von Haehling S; Bode-Böger SM; Martens-Lobenhoffer J; Rauchhaus M; Schefold JC; Genth-Zotz S; Karhausen T; Cicoira M; Anker SD; Doehner W
    Clin Pharmacol Ther; 2010 Oct; 88(4):506-12. PubMed ID: 20827268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase.
    Landmesser U; Spiekermann S; Dikalov S; Tatge H; Wilke R; Kohler C; Harrison DG; Hornig B; Drexler H
    Circulation; 2002 Dec; 106(24):3073-8. PubMed ID: 12473554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase inhibition protects against Western diet-induced aortic stiffness and impaired vasorelaxation in female mice.
    Lastra G; Manrique C; Jia G; Aroor AR; Hayden MR; Barron BJ; Niles B; Padilla J; Sowers JR
    Am J Physiol Regul Integr Comp Physiol; 2017 Aug; 313(2):R67-R77. PubMed ID: 28539355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.
    Givertz MM; Anstrom KJ; Redfield MM; Deswal A; Haddad H; Butler J; Tang WH; Dunlap ME; LeWinter MM; Mann DL; Felker GM; O'Connor CM; Goldsmith SR; Ofili EO; Saltzberg MT; Margulies KB; Cappola TP; Konstam MA; Semigran MJ; McNulty SE; Lee KL; Shah MR; Hernandez AF;
    Circulation; 2015 May; 131(20):1763-71. PubMed ID: 25986447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure.
    Gavin AD; Struthers AD
    Heart; 2005 Jun; 91(6):749-53. PubMed ID: 15894768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid in chronic heart failure.
    Doehner W; Anker SD
    Semin Nephrol; 2005 Jan; 25(1):61-6. PubMed ID: 15660337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function in chronic congestive heart failure.
    Drexler H; Hayoz D; Münzel T; Hornig B; Just H; Brunner HR; Zelis R
    Am J Cardiol; 1992 Jun; 69(19):1596-601. PubMed ID: 1598876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.